74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Beauty Health Co
Closed
0.9 2.27
Overview
Share price change
24h
Min
0.86
Max
0.91
Income | 3M -8.1M |
|---|---|
Sales | 12M 82M |
EPS | -0.06 |
Profit margin | -9.806 |
Employees | 613 |
EBITDA | 1.4M 5.5M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +113.64% upside |
Next Earnings | 7 May 2026 |
|---|
Market Cap | -38M 113M |
|---|---|
Previous open | -1.37 |
Previous close | 0.9 |
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
Beauty Health Co Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Beauty Health Co Forecast
Price Target
By TipRanks
113.64% upside
12 Months Forecast
Average 1.88 USD 113.64%
High 2.5 USD
Low 1.5 USD
Based on 5 Wall Street analysts offering 12 month price targets forBeauty Health Co - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Beauty Health Co
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Live chat